TargetPotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.16E+3nMAssay Description:Inhibition of human HCN3 heterologously expressed in HEK-293 cells after 30 mins by VIPR assayMore data for this Ligand-Target Pair